Showing 81-90 of 215 results for "".
Is Your Practice’s Retirement Plan a Liability Trap?
https://practicaldermatology.com/topics/practice-management/is-your-practices-retirement-plan-a-liability-trap/22984/Why A 401(k) can cause liability for dermatologists and how to mitigate this riskWebsite Rankings of Dermatology Associations; News and Trends
https://practicaldermatology.com/youngmd-connect/resident-resource-center/website-rankings-of-dermatology-associations-news-and-trends/20854/Case Study: A Verrucous Plaque of the Nose
https://practicaldermatology.com/topics/practice-management/case-study-a-verrucous-plaque-of-the-nose/21101/What caused a progressively enlarging mass starting along the nasal septum and extending to the sidewall?Six Tax Reduction Strategies to Enhance Portfolio Performance
https://practicaldermatology.com/topics/practice-management/six-tax-reduction-strategies-to-enhance-portfolio-performance/20794/Tax planning requires attention throughout the year.The Tax Cuts and Jobs Act: What You Need to Know
https://practicaldermatology.com/topics/practice-management/the-tax-cuts-and-jobs-act-what-you-need-to-know/20529/An overview of changes that may impact dermatologists and their practices.Reviving the Dream: Correcting Suboptimal Results from Injectable Treatments
https://practicaldermatology.com/topics/general-topics/PD0309_10-php/22864/Skill, patience and meticulous selection of products and injection techniques are pre-requisites for satisfactory correction of a poor outcome from treatment with dermal fillers and botulinum toxin.Case Report: First Reported Case of Facial Rash After Dupilumab Therapy; Call for Abstracts
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-first-reported-case-of-facial-rash-after-dupilumab-therapy-call-for-abstracts/20499/New in My Practice: Cosmeceutical
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-cosmeceutical/23943/Why Has the Market Gone Up When Economic News Looks Grim?
https://practicaldermatology.com/topics/practice-management/why-has-the-market-gone-up-when-economic-news-looks-grim/23314/A look at seven factors affecting the market.Biologics for Psoriasis: A Status Update
https://practicaldermatology.com/topics/psoriasis/biologics-for-psoriasis-a-status-update/23006/The field has grown substantially from the early 2000s to include now a dozen innovator systemic agents, a host of biosimilars, and soon JAK Inhibitors.